The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice (original) (raw)

References

  1. Lippman ME: Growth regulation of human breast cancer. Clin Res 33: 375–382, 1982
    Google Scholar
  2. Baserga R: Oncogenes and the strategy of growth factors. Cell 79: 927–930, 1994
    Google Scholar
  3. Le Roith D, Baserga R, Helman L, Roberts CT: Insulin-like growth factors and cancer. NIH Conference, Ann Int Med 122: 54–58, 1995
    Google Scholar
  4. Dickson RB, Lippman ME: Growth factors in breast cancer. Endocr Rev 16: 559–589, 1995
    Google Scholar
  5. Baserga R: The insulin-like growth factor I receptor: a key to tumor growth. Cancer Res 55: 249–252, 1995
    Google Scholar
  6. Yarden Y, Ullrich A: Growth factor receptor tyrosine kinases. Ann Rev Biochem 57: 443–478, 1988
    Google Scholar
  7. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J: Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature (Lond) 313: 756–761, 1985
    Google Scholar
  8. Goldfine ID: The insulin receptor: molecular biology and transmembrane signalling. Endocr Rev 8: 235–255, 1987
    Google Scholar
  9. Strauss DS: Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 5: 356–369, 1984
    Google Scholar
  10. Frittitta L, Vigneri R, Stampfer MR, Goldfine ID: Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand dependent transformed phenotype. J Cell Biochem 57: 666–669, 1995
    Google Scholar
  11. Giorgino F, Belfiore A, Milazzo G, Constantino A, Maddux BA, Whittaker J, Goldfine ID, Vigneri R: Overexpression of insulin receptor in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol 5: 452–459, 1991
    Google Scholar
  12. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID, Vigneri R: Elevated insulin receptor content in human breast cancer. J Clin Invest 86: 1503–1510, 1990
    Google Scholar
  13. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID, Belfiore A: Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52: 3924–3930, 1992
    Google Scholar
  14. Cardiff RD, Muller WJ (eds): Transgenic mouse models of mammary tumorigenesis. In: Cancer Surveys, Vol. 16: The Molecular Pathology of Cancer. Imperial Cancer Research Foundation (ed). Vol. 16, 1993, pp 97–113
  15. Cardiff RD, Sinn E, Muller WJ, Leder P: Transgenic oncogene mice. Amer J Pathology 139: 485–501, 1991
    Google Scholar
  16. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619–625, 1988
    Google Scholar
  17. Grieco M, Santoro M, Berlingieri RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G: PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557–556, 1990
    Google Scholar
  18. Iwamoto T, Takahashi M, Ito M, Hamaguchi M, Isobe K, Misawa N, Asai J, Yoshida T, Nakashima I: Oncogenicity of the ret transforming gene in MMTV ret transgenic mice. Oncogene 5: 535–542, 1990
    Google Scholar
  19. Lucchini F, Sacco MG, Nanpin H, Villa A, Brown J, Cesano L, Mangiarini L, Rindi G, Kindl S, Sessa F, Vezzoni P, Clerici L: Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTY-Neu transgenic mice. Cancer Lett 64: 203–209, 1992
    Google Scholar
  20. Pezzino V, Papa V, Trischitta V, Brunetti A, Goodman PA, Treutelar MK, Williams JA, Maddux BA, Vigneri R, Goldfine ID: Human insulin receptor radio-immunoassay: applicability to insulin-resistant states. Am J Physiol 257: E451–457, 1989
    Google Scholar
  21. Takami O, Perry JW, Topper YJ: Changes in insulin responsiveness during development of mammary epithelium. J Cell Biol 62: 550–556, 1974
    Google Scholar
  22. O'Keefe E, Cuatrecasas P: Insulin receptor in murine mammary cells: comparison in pregnant and non pregnant animals. Biochem Biophys Acta 343: 64–67, 1974
    Google Scholar
  23. Echelard F, Vassileva G, McMahon AP: Cis-acting regulatory sequences governing Wnt-1 expression in the developing mouse CNS. Development 120(8): 2213–2224, 1994
    Google Scholar
  24. Bergmann CI, Hung MC, Weinberg RA: The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226–230, 1986
    Google Scholar
  25. Le Marchand L, Kolonel LN, Earle ME, Mi MP: Body size at different periods of life and breast cancer risk. Am J Epidemiol 138: 137–152, 1988
    Google Scholar
  26. Schapira DV, Kumar NB, Lyman GH, Cox CE: Abdominal obesity and breast cancer risk. Ann Int Med 112: 182–186, 1990
    Google Scholar
  27. Pathak DR, Whittemore AS: Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol 135: 153–168, 1992
    Google Scholar
  28. Heuson JC, Legros N: Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to niloxan diabetes and food restriction. Cancer Res 32: 226–232, 1972
    Google Scholar
  29. Heuson JC, Legros N, Heimann R: Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized and hypophysectomized rats. Cancer Res 32: 233–238, 1972
    Google Scholar
  30. Jorgensen LN, Didenksen LH, Drejer K: Carcinogenic effect of the human insulin analogue B10Asp in female rats. Diabetes 41(Suppl. 1): 143A, 1992
    Google Scholar

Download references